15.3 Hypoglycemia Risk in Combination Therapy While semaglutide alone rarely causes hypoglycemia, co-administration with insulin or sulfonylureas increases risk significantly
If you notice any changes in vision or eye problems while taking Rybelsus, speak with your doctor, as rapid improvements to your blood sugar can sometimes temporarily worsen diabetic eye disease
GLP-1 medical weight management may be considered for adults who are overweight or obese, especially if weight is affecting metabolic health, cardiovascular risk, or overall wellbeing
Whilst GLP-1 medications are effective for weight reduction, aiming for a gradual loss of 0.51 kg per week is generally safer and more sustainable, in line with NHS guidance
The amount of weight you can expect to lose with semaglutide varies based on individual factors such as starting weight, adherence to a healthy lifestyle, and the dosage prescribed